Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Daniel Patricia"'
Publikováno v:
The Accounting Review, 2002 Jul 01. 77(3), 679-693.
Externí odkaz:
https://www.jstor.org/stable/3068892
Autor:
Daniel, Patricia L.
Publikováno v:
The English Journal, 1996 Mar 01. 85(3), 32-35.
Externí odkaz:
https://www.jstor.org/stable/820100
Autor:
Daniel, Patricia Anne
This thesis presents a study of the answers that contemporary women give to the question Jesus asked of the disciples: “Who do you say that I am?”. It explores the way in which women, throughout their faith journeys, negotiate and renegotiate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56058346a474b9926cc73bcc34f19101
Autor:
Wells, Rebecca1 rebecca.wells1@uga.edu, Daniel, Patricia1, Barger, Brian1, Rice, Catherine E.2, Bandlamudi, Maitreyi1, Crimmins, Daniel1
Publikováno v:
Children's Health Care. Apr-Jun2021, Vol. 50 Issue 2, p171-191. 21p. 6 Charts.
Autor:
Roland Elmar Knoblauch, Sumit K. Subudhi, Dirk G. Brockstedt, Suzette Girgis, Enrique Zudaire, Nibedita Bandyopadhyay, Mark Wade, Jeffrey R. Infante, Russell K. Pachynski, Dolly A. Parasrampuria, Douglas G. McNeel, Nicole L. Stone, Charles G. Drake, Peter Lauer, Lawrence Fong, Gary Mason, Daniel Patricia, Todd M. Bauer, Emmanuel S. Antonarakis, Marco Gottardis
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:219-228
Background The safety and immunogenicity of JNJ-64041809 (JNJ-809), a live-attenuated, double-deleted Listeria monocytogenes (LADD Lm)-based immunotherapy targeting 4 relevant prostate cancer antigens, was evaluated in a phase 1 study in patients wit
Autor:
DANIEL, PATRICIA
Publikováno v:
Cuban Studies, 2011 Jan 01. 42, 52-56.
Externí odkaz:
https://www.jstor.org/stable/24487500
Autor:
Daniel, Patricia L.
Publikováno v:
The English Journal, 2007 May 01. 96(5), 75-80.
Externí odkaz:
https://www.jstor.org/stable/30046715
Autor:
Michael J. Morris, A. Oliver Sartor, Jeffrey Y.C. Wong, Steven I Max, Hong Xie, Alex Yu, Chaitanya R. Divgi, Daniel Patricia, Anjali Narayan Avadhani, Neeta Pandit-Taskar, Pedro C. Barata, Luke T. Nordquist
Publikováno v:
Journal of Clinical Oncology. 40:TPS5104-TPS5104
TPS5104 Background: Radioligand therapy for metastatic castration resistant prostate cancer (mCRPC) has been shown to prolong survival, delay disease progression, and improve quality of life, raising hopes that these gains will be amplified with even
Autor:
Daniel, Patricia
Publikováno v:
Equal Opportunities International, 2000, Vol. 19, Issue 2/3/4, pp. 17-24.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/02610150010786229
Autor:
Daniel, Patricia
Publikováno v:
Equal Opportunities International, 2000, Vol. 19, Issue 2/3/4, pp. 3-7.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/02610150010786201